Carbylan Therapeutics, Inc.

-

Assets, Funds, Holdings

Home | Sign Up | Log In
Message
Happy Holidays!! thanks for using AUM13F!!
List of Funds
Boston Firms
Boston Hedge Funds
Cornell Alumni Firms
CalPERS Portfolio
NYSCRF Portfolio
User Guide
Regulatory AUM vs AUM
LP Portfolios
Related Firms
Build a Portfolio
Comprehensive Search
Carbylan Therapeutics, Inc.
CIK #0001348911
EDGAR Form CIK 2011 - 2025
10-K [0001348911]
10-Q [0001348911]
3 [0001348911]
4 [0001348911]
8-K [0001348911]
D [0001348911]
SC 13D [0001348911]
SC 13G [0001348911]
Form 13D/13G Filer Form 13D/13G Subject Filed
Vestal Point Capital LP KalVista Pharmaceuticals Inc [2024-11-14]
Capital World Investors KalVista Pharmaceuticals Inc [2024-11-13]
Adage Capital Partners GP LLC KalVista Pharmaceuticals Inc [2024-02-26]
Vanguard Group Inc KalVista Pharmaceuticals Inc [2024-02-13]
Saturn V Capital Management LP KalVista Pharmaceuticals Inc [2024-02-12]
BlackRock Inc KalVista Pharmaceuticals Inc [2024-01-29]
Suvretta Capital Management LLC KalVista Pharmaceuticals Inc [2023-03-10]
FMR LLC KalVista Pharmaceuticals Inc [2023-02-09]
TCG Crossover GP I LLC KalVista Pharmaceuticals Inc [2023-01-09]
Venrock Healthcare Capital Partners III LP KalVista Pharmaceuticals Inc [2023-01-09]
View All
Form 3/4/5 Subject 2011 - 2025
KalVista Pharmaceuticals, Inc.
Palleiko Benjamin L
Audhya Paul K.
Yea Christopher
Shah Nimish P
Koh Bong Y
Venrock Healthcare Capital Partners III, L.P.
VHCP Co-Investment Holdings III, LLC
VHCP Management III, LLC
VHCP Management EG, LLC
View All
Terms | Privacy | Guide
tony@aum13f.com